{"id":719,"date":"2026-06-07T23:42:32","date_gmt":"2026-06-07T23:42:32","guid":{"rendered":"https:\/\/biosynlab.com\/?post_type=product&p=719"},"modified":"2026-06-21T09:43:50","modified_gmt":"2026-06-21T09:43:50","slug":"vinpocetine-capsules-15mg","status":"publish","type":"product","link":"https:\/\/www.biosynlab.com\/?product=vinpocetine-capsules-15mg","title":{"rendered":"Vinpocetine Capsules \u2013 15mg"},"content":{"rendered":"

BIOSYNLAB Vinpocetine Capsules \u2013 15mg Pharmaceutical Grade<\/h1>\n

 <\/p>\n

Product Details Table<\/h2>\n

 <\/p>\n

\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Specification<\/strong><\/th>\nDetails<\/strong><\/th>\n<\/tr>\n<\/thead>\n
Brand<\/strong><\/td>\nBIOSYNLAB Research Compounds<\/td>\n<\/tr>\n
Product Name<\/strong><\/td>\nVinpocetine (AY-27255) Synthetic Alkaloid Capsules<\/td>\n<\/tr>\n
IUPAC Name<\/strong><\/td>\nEthyl (3\u03b1,16\u03b1)-14,15-dihydro-14-hydroxyeburnamenine-14-carboxylate<\/td>\n<\/tr>\n
CAS Number<\/strong><\/td>\n42971-09-5<\/td>\n<\/tr>\n
Synonyms<\/strong><\/td>\nAY-27255, RGH-4405, Cavinton, Ethyl Apovincaminate<\/td>\n<\/tr>\n
Molecular Formula<\/strong><\/td>\nC\u2082\u2082H\u2082\u2086N\u2082O\u2082<\/td>\n<\/tr>\n
Molecular Weight<\/strong><\/td>\n350.46 g\/mol<\/td>\n<\/tr>\n
Purity Grade<\/strong><\/td>\n\u226599.0% (EP\/USP standard, HPLC verified)<\/td>\n<\/tr>\n
Formulation<\/strong><\/td>\n15mg per vegetarian capsule<\/td>\n<\/tr>\n
Appearance<\/strong><\/td>\nWhite to off-white crystalline powder in clear HPMC capsules<\/td>\n<\/tr>\n
Melting Point<\/strong><\/td>\n149-153\u00b0C<\/td>\n<\/tr>\n
Specific Rotation<\/strong><\/td>\n[\u03b1]\u00b2\u2070D +115\u00b0 to +120\u00b0 (C=2, pyridine)<\/td>\n<\/tr>\n
Mechanism<\/strong><\/td>\nPDE1 inhibitor, cerebral vasodilator, calcium channel modulator<\/td>\n<\/tr>\n
Packaging<\/strong><\/td>\nAmber borosilicate vials, argon-purged, desiccated<\/td>\n<\/tr>\n
Storage<\/strong><\/td>\n2-8\u00b0C refrigerated, light-protected, moisture-free<\/td>\n<\/tr>\n
Batch Analysis<\/strong><\/td>\nCOA, HPLC chromatogram, optical rotation data<\/td>\n<\/tr>\n
Origin<\/strong><\/td>\nGMP-certified synthesis facility<\/td>\n<\/tr>\n
Shipping<\/strong><\/td>\nCold-chain logistics, customs documentation included<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n
\n

Cerebrovascular Pharmacology: The Synthetic Alkaloid Standard<\/h2>\n

Are you investigating cerebral blood flow modulation, phosphodiesterase inhibition, or neuroprotective mechanisms in ischemic conditions?<\/strong>\u00a0BIOSYNLAB delivers pharmaceutical-grade Vinpocetine capsules\u2014synthesized to exacting specifications for neurovascular research,<\/a> stroke modeling, and cognitive pharmacology laboratories across the USA, Europe, and United Kingdom markets.<\/p>\n

Vinpocetine (ethyl apovincaminate, AY-27255) represents the semisynthetic evolution of the vincamine alkaloid, optimized for enhanced bioavailability and targeted cerebrovascular activity. Originally developed by the Richter Gedeon pharmaceutical laboratories, this synthetic derivative has emerged as a critical reference compound for investigating cyclic nucleotide phosphodiesterases, cerebral metabolism, and neuronal protection under hypoxic and ischemic stress.<\/p>\n

Our synthesis protocol employs stereoselective esterification of apovincaminic acid, delivering the pharmacologically active (3\u03b1,16\u03b1)-cis configuration with chiral purity exceeding 99%. Each batch undergoes rigorous analytical verification to ensure compliance with European Pharmacopoeia (EP) and United States Pharmacopeia (USP) standards.<\/p>\n

\n

Chemical Structure & Mechanism of Action<\/h2>\n

Structural Classification:<\/strong>\u00a0Vinpocetine is a synthetic vinca alkaloid derivative featuring:<\/p>\n